Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
255.00    -5.00 (-1.92%)
Bid:
250.00
Ask:
260.00
Spread: 10.00 (4.00%)
Market Cap: £123.56m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Interim Results Timetable and Trading Update

7 Jul 2021 07:00

RNS Number : 3740E
Quartix Technologies PLC
07 July 2021
Β 

Quartix Technologies plc

("Quartix", "the Group" or "the Company")

Interim results timetable and trading update

Quartix Technologies plc, a leading supplier of subscription-based vehicle tracking systems, software and services in the UK, announces that it will publish interim results for the six-month period ending 30 June 2021 (the "Period") on Wednesday 28 July 2021. They will be posted on the Company's website that morning, together with accompanying presentations.

Β 

The Company is pleased to report that trading for the first 6 months of the year has been good, following a period of strong growth in new fleet telematics installations, and in line to achieve consensus market expectations for the year1. The Board expects to report revenue of Β£12.5m, adjusted EBITDA of approximately Β£2.7m and underlying free cash flow2 of approximately Β£1.3m for the Period. The Company's cash balance was Β£4.2m at 30 June 2021.

Β 

Although the sourcing of electronic components has been challenging during the first half, the Group has been able to secure its production supplies and remains confident of doing so through the rest of 2021. This has, however, been at the expense of higher costs in some cases and of needing to purchase larger quantities where components are available. This has had an impact on free cashflow in the Period and could have a moderate impact on free cashflow for the year as a whole if contingency stock levels need to be increased, but the additional costs are not expected to have a material impact on the Company's expected financial performance for the year.

Β 

Fleet telematics

Β 

The Company achieved strong growth in new installations, which were 31% ahead of H1 2020, at 25,497 units. This result was also 13% ahead of the same period in 2019, which was previously the highest recorded for a 6-month period. All major territories are now operating at above pre-pandemic levels with the exception of the UK, where record orders in H1 2019 were driven by a significant number of larger contract wins and distribution orders. This will be an area of focus for the Company's sales teams as contact restrictions are lifted.

Β 

New installations in international markets exceeded those in the UK for the first time, and performance in the Group's new territories and France were particularly encouraging. Further investment initiatives are already underway which are expected to contribute to continued growth in the second half.

Β 

As a consequence of the growth in new installations, the fleet subscription base at 30 June increased to 188,155 vehicles, up 8% since the start of the year. The Company now has 20,698 fleet clients (1 January 2021: 19,039).

Β 

New fleet telematics installations for the first half are shown in the table below. Exact totals may vary in preparation of the interim results.

Β 

2021

2020

Growth

2019

2021 vs. 2019

UK/Eire

12,053

10,017

20%

13,369

-10%

France

5,631

3,959

42%

4,461

26%

USA

4,852

4,274

14%

4,365

11%

New territories*

2,961

1,230

141%

309

858%

Total

25,497

19,480

31%

22,504

13%

Β 

* Note: new territories include Spain, Italy, Germany and Poland.

Β 

Insurance telematics

Β 

Further restrictions on driving tests and the young-driver market in the UK are expected to have reduced Company revenues in the insurance telematics sector by a further 60% compared with 2020, with 3,540 units installed in the first half (2020: 9,915).

Β 

In line with Quartix's stated strategy of focusing on fleet telematics, the insurance sector is expected to represent just 7% of H1 revenues and, given the current worldwide shortage of electronic components as described above, the Company has taken the decision to terminate the supply of new installations for its main insurance client in order to prioritise its fleet operations. Under a new agreement Quartix will only continue to provide tracking systems for the customer's existing policy holders and will provide data and warranty services for a contractually agreed monthly service fee until September 2022. This will not have a material impact on the Company's expected financial performance for the year. Insurance revenues in 2022 are expected to represent approximately 3% of Group turnover.

Β 

Andy Walters, Chief Executive Officer of Quartix commented:

Β 

"I am delighted with the growth in new installations achieved in our fleet business during the first half. Our focus on fleet and the strategic move away from insurance over the past 5 years has served us well during the pandemic and we continue to invest in building our sales channels in each territory. We look forward to the second half with confidence and to updating investors on progress in three weeks' time."

Β 

Β 

1 The Board believes that consensus market expectations for 2021 prior to this announcement, were as follows: Revenue: Β£25.6m; Adjusted EBITDA Β£5.1m; Underlying Free Cash Flow2: Β£4.0m.

2 Underlying Free Cash Flow stated before expenditure on 3G swap out in the US - see 2020 Annual Report

Β 

For further information, please contact:

QuartixΒ (www.quartix.net)

Andrew Walters, Chief Executive Officer

Emily Rees, Chief Financial Officer

Β 

01686 806 663

finnCap (Nominated Adviser and Broker)

Matt Goode / Kate Bannatyne / Milesh Hindocha (Corporate Finance)

Alice Lane (Corporate Broking)

020 7220 0500

Β 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NORFFFIIDTIRIIL
Date   Source Headline
2nd Jun 202612:17 pmRNSDirector/PDMR Shareholding
22nd Apr 20265:20 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
8th Apr 202612:16 pmRNSDirector/PDMR Dealing, TVR & Investor Webinar
25th Mar 20267:00 amRNSFinal Results
20th Mar 20264:18 pmRNSNotice of Results
23rd Feb 20267:00 amRNSNotice of Results
11th Feb 20267:00 amRNSFRC Review, Accounting Policy & Notice of Results
8th Jan 20267:00 amRNSTrading Update
15th Dec 20255:47 pmRNSDirector/PDMR Shareholding
18th Nov 20252:15 pmRNSHolding(s) in Company
27th Oct 202512:49 pmRNSDirector/PDMR Shareholding
6th Oct 20255:37 pmRNSGrant of Options
6th Oct 20257:01 amRNS-RMelloMonday Investor Webinar
6th Oct 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNSInterim Results
3rd Jul 20257:00 amRNSTrading Statement
7th Apr 20257:00 amRNSTrading Statement
31st Mar 20253:52 pmRNSDirector/PDMR Shareholding
31st Mar 20251:30 pmRNSResult of AGM
31st Mar 20257:00 amRNSAGM Trading Statement
3rd Mar 20257:00 amRNSFinal Results
13th Feb 202510:00 amRNSInvestor Presentation via Investor Meet Company
13th Jan 20257:00 amRNSTrading Statement
15th Oct 20247:00 amRNSTrading Statement
28th Aug 202410:58 amRNSDirector/PDMR Shareholding
29th Jul 20247:00 amRNSInterim Results
8th Jul 20247:00 amRNSTrading Statement
15th May 20246:24 pmRNSGranting of Options
27th Mar 20244:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAGM Trading Statement and Directorate Change
4th Mar 20247:00 amRNSFinal Results
19th Feb 20247:00 amRNSDirectorate Changes
24th Jan 20245:45 pmRNSHolding(s) in Company
23rd Jan 20245:00 pmRNSDirector/PDMR Shareholding - Replacement
23rd Jan 20241:09 pmRNSDirector/PDMR Shareholding
17th Jan 20243:51 pmRNSHolding(s) in Company
17th Jan 20241:45 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSTrading Statement
18th Dec 202311:45 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSKonetik update
28th Nov 20237:00 amRNSDirectorate Changes
10th Nov 20234:01 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSBoard Changes - Replacement
10th Oct 20235:00 pmRNSBoard Changes
6th Oct 20237:00 amRNSTrading Update
26th Sep 20237:00 amRNSDirectorate Change
21st Sep 202311:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSAcquisition of Konetik GmBH
3rd Aug 20233:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.